P654Effectiveness of evolocumab for patients with familial hypercholesteraemia (FH) in European clinical practice
Sign Up to like & getrecommendations! Published in 2019 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehz747.0261
Abstract: FH is a genetic disorder which causes lifelong elevations in LDL-C from birth, resulting in a significantly increased risk of premature atherosclerotic cardiovascular disease (ASCVD). In clinical trials among patients with heterozygous FH (HeFH) and… read more here.
Keywords: clinical practice; ldl; evolocumab; hefh hofh ... See more keywords